The role of the HDAC3/HNF4A/TYMS axis in the chidamide-modulated sensitivity of GC cells to drugs was further elucidated by knocking down TYMS while overexpressing HDAC3 in GC cells following chidamide treatment. Here, TYMS is linked to gastric cancer.